Related Experiment Videos
Apoptosis in rheumatoid arthritis
Anja Baier1, Ingmar Meineckel, Steffen Gay
1Division of Experimental Rheumatology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Current Opinion in Rheumatology
|April 23, 2003
Summary
Rheumatoid arthritis involves altered apoptosis in synovial cells, particularly fibroblast resistance to programmed cell death, contributing to cartilage destruction. Research aims to identify molecular targets to correct this altered apoptosis.
Area of Science:
- Cell Biology
- Immunology
- Rheumatology
Background:
- Apoptosis is crucial for tissue homeostasis, and its dysregulation in synovial cells is implicated in rheumatoid arthritis (RA) pathogenesis.
- Altered apoptosis in RA synovial fibroblasts contributes to chronic inflammation, hyperplasia, and progressive articular cartilage destruction.
Purpose of the Study:
- To investigate the mechanisms underlying resistance to apoptosis in rheumatoid arthritis synovial fibroblasts.
- To identify key molecules regulating apoptosis in RA and potential therapeutic targets.
Main Methods:
- The study focuses on identifying and characterizing antiapoptotic molecules and transcriptional regulators involved in RA synovial fibroblast apoptosis.
- Investigates downstream modulators of Fas-signaling, including sentrin-1/small ubiquitin-like modifier (SUMO)-1 and Fas-associated death domain-like interleukin (IL)-1beta-converting enzyme-inhibitory protein (FLIP).
- Examines the role of transcriptional regulators such as NF-kappaB, Stat3, and p53 in regulating apoptosis.
Main Results:
- Several antiapoptotic molecules, including SUMO-1 and FLIP, have been identified as potentially regulating apoptosis in RA.
- Transcriptional regulators like NF-kappaB, Stat3, and p53 are suggested to play prominent roles in controlling apoptosis.
- Synovial fibroblast resistance to apoptosis is a key factor in RA, linked to cartilage damage.
Conclusions:
- Understanding the specific roles of identified molecules in rheumatoid fibroblast apoptosis is critical.
- Identifying molecular targets to interfere with altered apoptosis holds therapeutic potential for rheumatoid arthritis.